Literature DB >> 12151887

Orthopaedic manifestations of neurofibromatosis in children: an update.

Michael G Vitale1, Abhijit Guha, David L Skaggs.   

Abstract

Neurofibromatosis is one of the most common genetic disorders affecting mankind. Despite extensive basic science research, the diagnosis still is based largely on well-defined clinical criteria, which often present gradually during childhood. Approximately 50% of patients have significant musculoskeletal manifestations, with scoliosis and congenital pseudarthrosis of the tibia most common. Approximately 20% of children with Type I neurofibromatosis present with scoliosis with or without the classic dystrophic features, such as vertebral scalloping and rib penciling. Dystrophic curves portend rapid progression and require early fusion. Surgical treatment often is challenging because of the common presence of neurofibromas adjacent to the spinal cord, significant multiplanar deformity, and poor bone quality. Congenital pseudarthrosis of the tibia also continues to present significant difficulties. The use of a brace is the mainstay of early treatment, whereas intramedullary rodding commonly is used for operative fixation. Grafting of the free fibula and correction using techniques of distraction and compression histiogenesis with Ilizarov fixators have been reported for refractory cases with varying degrees of success. Multiple heroic, operative attempts may have a tremendous toll on the quality of life of affected children through their early childhood. In addition to these and other distinctive musculoskeletal lesions, affected children often suffer from various medical problems.

Entities:  

Mesh:

Year:  2002        PMID: 12151887     DOI: 10.1097/00003086-200208000-00013

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  29 in total

Review 1.  Spinal deformity in neurofibromatosis type-1: diagnosis and treatment.

Authors:  Athanasios I Tsirikos; Asif Saifuddin; M Hilali Noordeen
Journal:  Eur Spine J       Date:  2005-02-15       Impact factor: 3.134

2.  Migration of the penetrated rib head following deformity correction surgery without rib head excision in dystrophic scoliosis secondary to type 1 Neurofibromatosis.

Authors:  Saihu Mao; Benlong Shi; Shoufeng Wang; Chengyue Zhu; Zezhang Zhu; Bangping Qian; Feng Zhu; Xu Sun; Zhen Liu; Yong Qiu
Journal:  Eur Spine J       Date:  2015-01-07       Impact factor: 3.134

3.  Bone resorption in syndromes of the Ras/MAPK pathway.

Authors:  D A Stevenson; E L Schwarz; J C Carey; D H Viskochil; H Hanson; S Bauer; H-Y Cindy Weng; T Greene; K Reinker; J Swensen; R J Chan; F-C Yang; L Senbanjo; Z Yang; R Mao; M Pasquali
Journal:  Clin Genet       Date:  2011-01-19       Impact factor: 4.438

4.  Pediatric 25-hydroxyvitamin D concentrations in neurofibromatosis type 1.

Authors:  David A Stevenson; David H Viskochil; John C Carey; Xiaoming Sheng; Mary Murray; Laurie Moyer-Mileur; Judd Shelton; William L Roberts; Ashley M Bunker; Heather Hanson; Stephanie Bauer; Jacques L D'Astous
Journal:  J Pediatr Endocrinol Metab       Date:  2011       Impact factor: 1.634

5.  Successful treatment of congenital pseudarthrosis of the tibia: still a challenge.

Authors:  K Bobotas; S N Lallos; V S Nikolaou; D S Kοrres; N E Efstathopoulos
Journal:  Eur J Orthop Surg Traumatol       Date:  2012-09-02

6.  The reduced osteogenic potential of Nf1-deficient osteoprogenitors is EGFR-independent.

Authors:  S E Tahaei; G Couasnay; Y Ma; N Paria; J Gu; B F Lemoine; X Wang; J J Rios; F Elefteriou
Journal:  Bone       Date:  2017-10-12       Impact factor: 4.398

7.  Bone mineral density in children and adolescents with neurofibromatosis type 1.

Authors:  David A Stevenson; Laurie J Moyer-Mileur; Mary Murray; Hillarie Slater; Xiaoming Sheng; John C Carey; Bukhosi Dube; David H Viskochil
Journal:  J Pediatr       Date:  2007-01       Impact factor: 4.406

8.  Lower extremity strength and hopping and jumping ground reaction forces in children with neurofibromatosis type 1.

Authors:  Barbara A Johnson; Bruce Macwilliams; John C Carey; David H Viskochil; Jacques L D'Astous; David A Stevenson
Journal:  Hum Mov Sci       Date:  2011-09-08       Impact factor: 2.161

9.  Hyperactive transforming growth factor-β1 signaling potentiates skeletal defects in a neurofibromatosis type 1 mouse model.

Authors:  Steven D Rhodes; Xiaohua Wu; Yongzheng He; Shi Chen; Hao Yang; Karl W Staser; Jiapeng Wang; Ping Zhang; Chang Jiang; Hiroki Yokota; Ruizhi Dong; Xianghong Peng; Xianlin Yang; Sreemala Murthy; Mohamad Azhar; Khalid S Mohammad; Mingjiang Xu; Theresa A Guise; Feng-Chun Yang
Journal:  J Bone Miner Res       Date:  2013-12       Impact factor: 6.741

10.  Tibial geometry in individuals with neurofibromatosis type 1 without anterolateral bowing of the lower leg using peripheral quantitative computed tomography.

Authors:  David A Stevenson; David H Viskochil; John C Carey; Hillarie Slater; Mary Murray; Xiaoming Sheng; Jacques D'Astous; Heather Hanson; Elizabeth Schorry; Laurie J Moyer-Mileur
Journal:  Bone       Date:  2008-12-11       Impact factor: 4.398

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.